Abstract:TFEB (transcription factor EB) is a master regulator of lysosomal biogenesis, function and autophagy. The transcriptional activity of TFEB is mainly controlled by its phosphorylation status mediated by the MTOR (mechanistic target of rapamycin [serine/threonine kinase]) complex 1 (MTORC1). At present, little is known whether other forms of posttranslational modifications (PTMs) such as acetylation also affects is transcriptional activity. In this study, we first observed that a well-established histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) activated lysosomal function in human cancer cells, a process independent of the MTORC1 pathway. Second, SAHA treatment activated TFEB transcriptional activity, as evidenced by increased TFEB luciferase activity and expression of its target genes. Third and more importantly, we observed the enhanced TFEB acetylation in SAHA-treated cells, with identification of 4 acetylation sites. Mutation of these 4 sites markedly diminished TFEB transcriptional activity and lysosomal function induced by SAHA. Finally, we found that TFEB acetylation was functionally implicated in SAHA-mediated autophagy and cell death in cancer cells. Taken together, our results demonstrate that TFEB acetylation is a novel form of PTMs in TFEB that plays an important role in determining its transcriptional activity, lysosomal function and autophagy in cancer cells.ABBREVIATIONS: ACAT1: acetyl-coenzyme A acetyltransferase 1; AHA: L-azidohomoalanine; AO: acidic orange; ATG: autophagy related; CLEAR: Coordinated Lysosomal Expression and Regulation; CQ: chloroquine; CTSB: cathepsin B; HATs: histone acetyltransferases; HDACIs: HDACs inhibitors; HDACs: histone deacetylases; IP: immunoprecipitation; MEFs: mouse embryonic fibroblasts; MS: mass spectrometry; MTOR: mechanistic target of rapamycin (serine/threonine kinase); MTORC1: mechanistic target of rapamycin (serine/threonine kinase) complex 1; PTMs: posttranslational modifications; SAHA: suberoylanilidehydroxamic acid; TFEB: transcription factor EB.

The Role of Acetylation in the Subcellular Localization of an Oncogenic Isoform of Translation Factor eIF5A

Requirement for P62 Acetylation in the Aggregation of Ubiquitylated Proteins under Nutrient Stress

Acetylation regulates the nucleocytoplasmic distribution and oncogenic function of karyopherin alpha 2 in lung adenocarcinoma

Translation Factor eIF5A, Modification with Hypusine and Role in Regulation of Gene Expression. eIF5A as a Target for Pharmacological Interventions

Acetylation Promotes TyrRS Nuclear Translocation to Prevent Oxidative Damage

Histone Deacetylases 1/2 As Critical Factors in Protein Synthesis and Tumorigenesis

How does acetylation regulate autophagy?

Lysine Acetylation and Succinylation in HeLa Cells and Their Essential Roles in Response to UV-induced Stress

Acetylation of translation machinery affected protein translation in E. coli

Global Profiling of Ribosomal Protein Acetylation Reveals Essentiality of Acetylation Homeostasis in Maintaining Ribosome Assembly and Function.

Identification of Acetylation-Dependent Regulatory Mechanisms That Govern the Oncogenic Functions of Skp2

Beyond Histones: Unveiling the Functional Roles of Protein Acetylation in Prokaryotes and Eukaryotes

Function changes of myocyte enhancer factor-2 after acetylation

Characterization of a Novel EB1 Acetylation Site Important for the Regulation of Microtubule Dynamics and Cargo Recruitment

Site-Specific Acetylation Of The Fetal Globin Activator Nf-E4 Prevents Its Ubiquitination And Regulates Its Interaction With The Histone Deacetylase, Hdac1

Acetylation of Lysine Ε-Amino Groups Regulates Aminoacyl-Trna Synthetase Activity in Escherichia Coli

The emerging roles of HDACs and their therapeutic implications in cancer

Dynamic regulation of eEF1A1 acetylation affects colorectal carcinogenesis

Functions and mechanisms of non-histone protein acetylation

Acetylation Modulates IL-2 Receptor Signaling in T Cells

Importance of TFEB acetylation in control of its transcriptional activity and lysosomal function in response to histone deacetylase inhibitors